

HY-U00157 · 50 mg
MedChemExpress · Cat: HY-U00157
Reach 3+ verified distributors
Manufacturer product page
medchemexpress.com/NSC297623.html
Description
Meseclazone W2395;NSC297623 exhibits inhibitory potency of secondary phase ADP aggregation. Meseclazone possesses anti-inflammatory, analgesic and antipyretic activity.







